Cargando…
Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
The immune system offers several mechanisms of response to harmful microbes that invade the human body. As a first line of defense, neutrophils can remove pathogens by phagocytosis, inactivate them by the release of reactive oxygen species (ROS) or immobilize them by neutrophil extracellular traps (...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458410/ https://www.ncbi.nlm.nih.gov/pubmed/37632068 http://dx.doi.org/10.3390/v15081726 |
_version_ | 1785097158963232768 |
---|---|
author | Roach, Dwayne R. Noël, Benoît Chollet-Martin, Sylvie de Jode, Mathieu Granger, Vanessa Debarbieux, Laurent de Chaisemartin, Luc |
author_facet | Roach, Dwayne R. Noël, Benoît Chollet-Martin, Sylvie de Jode, Mathieu Granger, Vanessa Debarbieux, Laurent de Chaisemartin, Luc |
author_sort | Roach, Dwayne R. |
collection | PubMed |
description | The immune system offers several mechanisms of response to harmful microbes that invade the human body. As a first line of defense, neutrophils can remove pathogens by phagocytosis, inactivate them by the release of reactive oxygen species (ROS) or immobilize them by neutrophil extracellular traps (NETs). Although recent studies have shown that bacteriophages (phages) make up a large portion of human microbiomes and are currently being explored as antibacterial therapeutics, neutrophilic responses to phages are still elusive. Here, we show that exposure of isolated human resting neutrophils to a high concentration of the Pseudomonas phage PAK_P1 led to a 2-fold increase in interleukin-8 (IL-8) secretion. Importantly, phage exposure did not induce neutrophil apoptosis or necrosis and did not further affect activation marker expression, oxidative burst, and NETs formation. Similarly, inflammatory stimuli-activated neutrophil effector responses were unaffected by phage exposure. Our work suggests that phages are unlikely to inadvertently cause excessive neutrophil responses that could damage tissues and worsen disease. Because IL-8 functions as a chemoattractant, directing immune cells to sites of infection and inflammation, phage-stimulated IL-8 production may modulate some host immune responses. |
format | Online Article Text |
id | pubmed-10458410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104584102023-08-27 Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate Roach, Dwayne R. Noël, Benoît Chollet-Martin, Sylvie de Jode, Mathieu Granger, Vanessa Debarbieux, Laurent de Chaisemartin, Luc Viruses Brief Report The immune system offers several mechanisms of response to harmful microbes that invade the human body. As a first line of defense, neutrophils can remove pathogens by phagocytosis, inactivate them by the release of reactive oxygen species (ROS) or immobilize them by neutrophil extracellular traps (NETs). Although recent studies have shown that bacteriophages (phages) make up a large portion of human microbiomes and are currently being explored as antibacterial therapeutics, neutrophilic responses to phages are still elusive. Here, we show that exposure of isolated human resting neutrophils to a high concentration of the Pseudomonas phage PAK_P1 led to a 2-fold increase in interleukin-8 (IL-8) secretion. Importantly, phage exposure did not induce neutrophil apoptosis or necrosis and did not further affect activation marker expression, oxidative burst, and NETs formation. Similarly, inflammatory stimuli-activated neutrophil effector responses were unaffected by phage exposure. Our work suggests that phages are unlikely to inadvertently cause excessive neutrophil responses that could damage tissues and worsen disease. Because IL-8 functions as a chemoattractant, directing immune cells to sites of infection and inflammation, phage-stimulated IL-8 production may modulate some host immune responses. MDPI 2023-08-12 /pmc/articles/PMC10458410/ /pubmed/37632068 http://dx.doi.org/10.3390/v15081726 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Roach, Dwayne R. Noël, Benoît Chollet-Martin, Sylvie de Jode, Mathieu Granger, Vanessa Debarbieux, Laurent de Chaisemartin, Luc Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate |
title | Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate |
title_full | Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate |
title_fullStr | Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate |
title_full_unstemmed | Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate |
title_short | Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate |
title_sort | human neutrophil response to pseudomonas bacteriophage pak_p1, a therapeutic candidate |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458410/ https://www.ncbi.nlm.nih.gov/pubmed/37632068 http://dx.doi.org/10.3390/v15081726 |
work_keys_str_mv | AT roachdwayner humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate AT noelbenoit humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate AT cholletmartinsylvie humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate AT dejodemathieu humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate AT grangervanessa humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate AT debarbieuxlaurent humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate AT dechaisemartinluc humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate |